CONFORMATION AND DYNAMICS OF DRUG-DNA INTERCALATION

被引:38
|
作者
HERZYK, P
NEIDLE, S
GOODFELLOW, JM
机构
[1] INST CANC RES, CANC RES CAMPAIGN BIOMOLEC STRUCT UNIT, SUTTON SM2 5NG, SURREY, ENGLAND
[2] UNIV LONDON BIRKBECK COLL, DEPT CRYSTALLOG, LONDON WC1E 7HX, ENGLAND
来源
基金
英国惠康基金;
关键词
D O I
10.1080/07391102.1992.10508633
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular dynamics simulations have been undertaken for a B-form dodecanucleotide duplex in solution with and without an intercalated proflavine molecule between the central C - G base pairs. The introduction of this simple intercalator affects both the conformational features and dynamic properties of the oligonucleotide double helix. Changes are seen in the rms atomic fluctuations and anisotropy of phosphate, sugar and base atoms. The backbone conformation is slightly changed on average and more sugars adopt the C3' endo conformation in the simulation of the complex compared with the simulation of the oligonucleotide alone. Both major and minor grooves becomes wider on average with the addition of the intercalating drug. Flanking A . T base pairs on both sides of the intercalation site have undergone an increase in flexibiity, with the base pairs, especially at the 5' side, having the N1 ... N3 hydrogen bonds being broken.
引用
收藏
页码:97 / 139
页数:43
相关论文
共 50 条
  • [31] Electrochemical Biosensors for Monitoring of Drug-DNA Interactions
    Congur, Gulsah
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (04) : 316 - 330
  • [32] QUANTITATIVE FOOTPRINTING ANALYSIS OF DRUG-DNA INTERACTIONS
    WARD, B
    REHFUSS, R
    KISSINGER, K
    GOODISMAN, J
    DABROWIAK, JC
    [J]. BIOPHYSICAL JOURNAL, 1988, 53 (02) : A3 - A3
  • [33] Advanced microscopy solutions for monitoring the kinetics and dynamics of drug-DNA targeting in living cells
    Errington, RJ
    Ameer-beg, SM
    Vojnovic, B
    Patterson, LH
    Zloh, M
    Smith, PJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (01) : 153 - 167
  • [34] Drug-DNA recognition: energetics and implications for design
    Haq, I
    Ladbury, J
    [J]. JOURNAL OF MOLECULAR RECOGNITION, 2000, 13 (04) : 188 - 197
  • [35] Thymol and carvacrol binding to DNA: Model for drug-DNA interaction
    Nafisi, S
    Hajiakhoondi, A
    Yektadoost, A
    [J]. BIOPOLYMERS, 2004, 74 (05) : 345 - 351
  • [36] NMR-STUDIES OF DRUG-DNA INTERACTIONS
    SEARLE, MS
    [J]. PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 1993, 25 : 403 - 480
  • [37] Partition of Thermodynamic Energies of Drug-DNA Complexation
    Kostjukov, V. V.
    Khomytova, N. M.
    Evstigneev, M. P.
    [J]. BIOPOLYMERS, 2009, 91 (09) : 773 - 790
  • [38] PORPHYRINS AS PROBES OF DNA-STRUCTURE AND DRUG-DNA INTERACTIONS
    RANER, G
    GOODISMAN, J
    DABROWIAK, JC
    [J]. ACS SYMPOSIUM SERIES, 1989, 402 : 74 - 89
  • [39] Interaction of zanamivir with DNA and RNA: Models for drug-DNA and drug-RNA bindings
    Nafisi, Shohreh
    Kahangi, Fatemeh Ghoreyshi
    Azizi, Ebrahim
    Zebarjad, Nader
    Tajmir-Riahi, Heidar-Ali
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2007, 830 (1-3) : 182 - 187
  • [40] Replication block by an enediyne drug-DNA deoxyribose adduct
    Kappen, LS
    Goldberg, IH
    [J]. BIOCHEMISTRY, 1999, 38 (01) : 235 - 242